BFRG — Bullfrog AI Holdings, Inc.

Is BFRG overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Health Information Services

Oversold As of August 19, 2026

Bullfrog AI Holdings, Inc. (BFRG) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Healthcare name (Health Information Services) last closed at $0.53. The rating moved from Neutral to Oversold on August 15, 2026.

See all oversold Healthcare stocks →

AI analysis

Bullfrog AI Holdings, Inc. (BFRG) is an early-stage AI healthcare company with thematic tailwinds from rising interest in healthcare analytics but significant company-specific execution and financing risks. Public information on recent financial performance is limited, suggesting constrained cash runway and a likelihood of future dilution unless meaningful revenue or partnership announcements occur. The stock is thinly traded and prone to volatility; near-term upside would most likely stem from clear commercial wins or strategic collaborations, while downside is tied to financing needs, competitive pressures, and regulatory/data-privacy hurdles. Watch for any upcoming corporate updates, partnering news, or fundraises to reassess valuation sensitivity and directional bias.

Key factors

  • Early-stage AI healthcare provider with a niche product set focused on clinical data/insights and workflow automation
  • Small market capitalization and thin liquidity create high volatility but also potential for outsized moves on news or partnerships
  • Sector-level interest in AI and healthcare data analytics provides thematic support for long-term relevance
  • Limited publicly available recent financial disclosures and EDGAR coverage increases uncertainty about cash runway and revenue traction
  • Potential near-term catalysts include any commercial partnerships, pilot program expansions, or product commercialization announcements
  • Macro backdrop is moderately constructive for growth-oriented small caps but not sufficient to offset company-specific execution risk

Risks

  • Weak or unclear financial health: likely limited cash runway and need for dilutive financing absent clear revenue growth
  • Low liquidity and small float amplify price swings and make market exits/entries difficult for larger positions
  • Execution risk on product commercialization, customer adoption and ability to demonstrate measurable ROI for healthcare buyers
  • Regulatory and data-privacy risks specific to healthcare AI deployments (HIPAA, state laws, FDA oversight where applicable)
  • Intense competition from well-funded incumbents and other AI-health startups with deeper domain or distribution capabilities
  • Potential for aggressive dilution from future equity raises that erode existing shareholders
  • Absence of strong social/analyst coverage limits sentiment-driven demand and discovery in retail/professional channels
  • Macro sensitivity: tightening risk appetite or widening credit spreads could disproportionately impact microcap technology names

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for BFRG — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.